Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
5 drugs in development
By Therapeutic Area
top 3
R&D Momentum
85/100
Pipeline Velocity
64/100
Trial Completion Rate
77/100
Pipeline Concentration
28/100
Pipeline Freshness
81/100
Strategic Signals
Activity
Last 14 days
A Double-blind, Randomized Trial Comparing Three Single Dose Injections for Knee Osteoarthritis
The Susceptibility of Speech to Noise
STRENGTHENS: Study To Refine the Effectiveness of New Generation Therapies for Suicide
Systemic Molecular Markers of Surgical Trauma in Periodontitis/Peri-implantitis Patients
Building Social and Structural Connections for the Prevention of Opioid Use Disorder Among Youth Experiencing Homelessness: An RCT Examining Biopsychosocial Mechanisms
High-resolution Contrast-Enhanced MRI of Atrial Fibrillation Patients Prior to FIRM Ablation
Delphi Study for Evaluation of Cardiothoracic Critical Care as a Subspecialty and Its Core Competencies
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)